Research Article

Involvement of RBP4 in Diabetic Atherosclerosis and the Role of Vitamin D Intervention

Table 2

Correlation among RBP4, 25(OH)D, and the other indicators in DM groups ().

IndicatorRBP425(OH)D

TG0.3040.036−0.2230.127
HDL-c−0.2820.0770.3820.007
LDL-c0.1950.229−0.3590.018
TC0.1360.1570.0930.407
FPG0.0790.595−0.0430.793
FINS0.3760.008−0.1290.429
Weight0.0960.556−0.1030.529
RBP4−0.3240.025
HOMA-IR0.513<0.001−0.4280.002
HOMA-β−0.2810.0790.3110.031
SBP0.3630.011−0.2700.092
CRP0.3420.0180.1720.138
AI10.402<0.001−0.3140.035
AI20.419<0.001−0.3780.002
25(OH)D−0.3280.023

TG: triglycerides; HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density lipoprotein cholesterol; TC: total cholesterol; FPG: fasting plasma glucose; FINS: fasting insulin; RBP4: retinol-binding protein 4; HOMA-IR: homeostasis model assessment of insulin resistance; HOMA-β: homeostasis model assessment β-cell function index; SBP: systolic blood pressure; CRP: C-reactive protein; AI1: atherogenic index; AI2: atherogenic index 2; 25(OH)D: 25-hydroxyvitamin D.